A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects
Clinical trial NCT03955666 · COMPLETED
Trial details
- NCT number
- NCT03955666
- Sponsor
- Provention Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-07
- Primary completion
- 2019-12-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.